ABOUT

As cannabis markets mature, understanding how patients and consumers behave is becoming a commercial advantage. This session explores the survey data, purchasing trends and behavioural signals shaping demand across medical and emerging adult-use markets, with a particular focus on Germany. From prescribing patterns and product preferences to the role of telemedicine, clinics and pharmacies, speakers will examine what the data tells us today, what remains unclear, and which drivers are likely to define the next phase of market growth.

Behind every product reaching patients or consumers is a supply chain under pressure from regulation, price shifts and changing market demand. This session unpacks the latest data on imports, exports, wholesale pricing and retail dynamics across Europe, highlighting how supply routes differ between key markets and what that means for operators. As competition grows and margins tighten, the discussion will focus on the trends reshaping cannabis trade and the supply chain strategies most likely to succeed.

Cultivation is becoming more precise, more data-led and more dependent on technology that can improve consistency, reduce cost and strengthen compliance. This session brings together operators and technology providers to showcase the latest developments in cultivation equipment, monitoring tools and performance analytics, backed where possible by trial data and real-world results. It is a chance to examine which innovations are delivering measurable value and how growers can use data to make smarter production decisions.

What happens next in Europe’s most important cannabis markets will depend on a mix of policy, pricing, patient demand and investment confidence. This interactive session invites attendees to explore different market scenarios using adjustable inputs and live discussion to test how key variables could shape outcomes in Germany and beyond. By bringing data and audience insight together, the session aims to move beyond static forecasts and create a more practical view of where the market may be heading.

Capital remains selective, but deal activity continues to reveal where investors see value in the cannabis sector. This panel explores the latest trends in M&A, private investment, public market activity and strategic partnerships, looking at where money is moving and why. With a focus on Europe in a global context, speakers will discuss what recent transactions say about market confidence, how companies are positioning for growth, and what it now takes to attract serious capital.